11. Myasthenia gravis Clinical trials / Disease details


Clinical trials : 332 Drugs : 234 - (DrugBank : 81) / Drug target genes : 45 - Drug target pathways : 127

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04101578
(ClinicalTrials.gov)
February 8, 201716/9/2019Clinical Prognosis and Progression of Myasthenia Gravis PatientsProspective Observational Trial to Evaluate Clinical Prognosis and the Risk Factors for Progression for Myasthenia Gravis PatientsMyasthenia GravisDrug: Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)Da, Yuwei, M.D.NULLRecruiting15 YearsN/AAll2000China
2JPRN-UMIN000015019
2014/09/0202/09/2014Initial therapy for myasthenia gravis of combined therapy for tacrolimus and IVIGInitial therapy for myasthenia gravis of combined therapy for tacrolimus and IVIG - Combined therapy for tacrolimus and IVIG Myasthenia gravisTacrolimus and IVIGKansai medical universityNULLRecruitingNot applicableNot applicableMale and Female20Not applicableJapan
3NCT01179893
(ClinicalTrials.gov)
March 20079/8/2010Intravenous Immunoglobulin and Plasma Exchange in Myasthenia GravisA Randomized Trial of Plasma Exchange vs. IVIG in the Treatment of Myasthenia GravisMyasthenia GravidBiological: IVIG;Procedure: PLEXUniversity Health Network, TorontoGrifols Therapeutics Inc.Completed18 YearsN/ABoth87Phase 4Canada
4NCT00306033
(ClinicalTrials.gov)
March 200421/3/2006Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia GravisIVIG Treatment Compared to Placebo in Patients With Myasthenia Gravis: A Randomized Clinical TrialMyasthenia GravisDrug: Intravenous ImmuneGlobulinUniversity Health Network, TorontoNULLCompleted18 YearsN/ABoth50Phase 3Canada